- Home
- SDGR vs ACHC Comparison
SDGR vs ACHC Comparison
Compare SDGR & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SDGR
- ACHC
- Stock Information
- Founded
- SDGR 1990
- ACHC 2005
- Country
- SDGR United States
- ACHC United States
- Employees
- SDGR 787
- ACHC N/A
- Industry
- SDGR Biotechnology: Pharmaceutical Preparations
- ACHC Medical Specialities
- Sector
- SDGR Health Care
- ACHC Health Care
- Exchange
- SDGR Nasdaq
- ACHC Nasdaq
- Market Cap
- SDGR 1.5B
- ACHC 1.7B
- IPO Year
- SDGR 2020
- ACHC N/A
- Fundamental
- Price
- SDGR $19.77
- ACHC $20.68
- Analyst Decision
- SDGR Buy
- ACHC Strong Buy
- Analyst Count
- SDGR 8
- ACHC 12
- Target Price
- SDGR $26.75
- ACHC $35.33
- AVG Volume (30 Days)
- SDGR 1.2M
- ACHC 2.0M
- Earning Date
- SDGR 11-05-2025
- ACHC 11-05-2025
- Dividend Yield
- SDGR N/A
- ACHC N/A
- EPS Growth
- SDGR N/A
- ACHC N/A
- EPS
- SDGR N/A
- ACHC 1.18
- Revenue
- SDGR $237,917,000.00
- ACHC $3,265,548,000.00
- Revenue This Year
- SDGR $22.73
- ACHC $7.20
- Revenue Next Year
- SDGR $19.85
- ACHC $6.65
- P/E Ratio
- SDGR N/A
- ACHC $17.54
- Revenue Growth
- SDGR 18.59
- ACHC 4.58
- 52 Week Low
- SDGR $16.60
- ACHC $17.13
- 52 Week High
- SDGR $28.47
- ACHC $47.08
- Technical
- Relative Strength Index (RSI)
- SDGR 45.00
- ACHC 30.20
- Support Level
- SDGR $20.10
- ACHC $22.59
- Resistance Level
- SDGR $21.23
- ACHC $23.77
- Average True Range (ATR)
- SDGR 1.07
- ACHC 0.82
- MACD
- SDGR -0.20
- ACHC -0.40
- Stochastic Oscillator
- SDGR 17.93
- ACHC 8.85
About SDGR Schrodinger Inc.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.
About ACHC Acadia Healthcare Company Inc.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.